Empagliflozin (Jardiance) – Diabetes & Heart Health
What is Empagliflozin?
Empagliflozin, sold under the brand name Jardiance, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that helps lower blood sugar levels in adults with type 2 diabetes. It also reduces the risk of heart failure and kidney complications in diabetic patients.
Benefits of Empagliflozin (Jardiance)
- Controls blood sugar: Helps lower glucose levels by increasing sugar excretion through urine.
- Reduces heart failure risk: Supports cardiovascular health in diabetic patients.
- Aids in weight loss: Helps promote slight weight reduction in some patients.
- Protects kidneys: Lowers the risk of kidney complications in diabetes.
Jardiance is taken once daily, often as part of a complete diabetes management plan.
Robert Klein (verified owner) –
All-around solid.
Clara Paul (verified owner) –
User-friendly system.
Clara Klein (verified owner) –
Worked instantly.
Nils Pohl (verified owner) –
Excellent experience.
Moritz König (verified owner) –
Top marks!